Strata Oncology Stock
HealthTechLooking to sell Strata Oncology stock or options?
Strata Oncology operates as an oncology company focused on enhancing the impact of precision medicine for cancer patients. The company collaborates with leading healthcare systems nationwide, which routinely send their cancer patients' biopsies to high-throughput CLIA-certified labs for genomic sequencing. Within days, results are delivered to the oncologist, detailing the tumor profile and identifying suitable therapies and clinical trials. This enables healthcare providers to offer actionable insights, significantly improving the lives of cancer patients.
Arboretum Ventures, Monashee Investment Management, Revelation Partners, eLab Ventures, Deerfield Management, Baird Capital, Cormorant Asset Management, Renaissance Venture Capital, Wellington Management, Pfizer Ventures, Merck Global Health Innovation Fund, Matt Killian, Highside Capital Management, Thermo Fisher Scientific.